Pharmalucence, Inc.

UEI
VFG7FHXXAMN3
CAGE
0UB47
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
sunpharma.com
Founded
1983
Employees
10K-50K
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Pharmalucence, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Radiopharmaceticals and supples Contract · W81K0024F0147 Medical Command $40,878
Various radiopharmacueticals Contract · W81K0024F0105 Medical Command $100,000
Radiopharmaceticals and supples Contract · W81K0023F0135 Medical Command $75,000
Various radiopharmacueticals Contract · W81K0023F0142 Medical Command $80,000
Radiopharmaceticals and supples Contract · W81K0022F0168 Medical Command $25,000

About Pharmalucence, Inc.

Pharmalucence, Inc. is a specialty pharmaceutical manufacturer registered in SAM.gov since 2001, specializing in the production and distribution of generic radiopharmaceutical products and supplies for medical diagnostic services. As a for-profit, corporate entity structured as a Subchapter S Corporation, the company primarily serves federal government agencies with critical medical supply contracts. The company focuses on providing radiopharmaceuticals that support nuclear medicine diagnostic services, particularly for military healthcare environments.

Pharmalucence, Inc. has been awarded multiple federal contracts by the Defense Health Agency (DHA), a component of the Department of Defense, for supplying radiopharmaceuticals and related medical supplies. These contracts, predominantly firm fixed-price blanket purchase agreement (BPA) call contracts, range in value from $25,000 to $100,000 and are designed to support nuclear medicine diagnostic services for military treatment facilities. The contract awards have consistently targeted the procurement of specialized radiopharmaceuticals used for imaging various medical conditions, including breast cancer nodules, liver malignancies, and gall bladder malignancies. Notably, most of these contracts have no specific set-aside designation, indicating open competition, and are aimed at supporting the Medical Health System's 9.5 million beneficiaries, including active duty personnel and their families.

Pharmalucence, Inc. holds two significant federal contract Indefinite Delivery Vehicles (IDVs): a $1.25 million BPA with the Department of the Army Medical Command for radiopharmaceutical supplies at Tripler Army Medical Center in Hawaii from May 2021 through April 2026, and a $1 million BPA to provide radiopharmaceuticals to various military treatment facilities from October 2020 through September 2025. These IDVs have enabled the Defense Health Agency to award multiple task orders, including contracts for facilities in Fort Sam Houston and El Paso, Texas. The IDVs are single-award contracts with no specific set-aside designation, demonstrating the company's capability to directly support military medical readiness through streamlined procurement of specialized pharmaceutical supplies.

Quick answers

What is Pharmalucence, Inc.'s UEI?

Pharmalucence, Inc.'s Unique Entity ID (UEI) in SAM.gov is VFG7FHXXAMN3.

What is Pharmalucence, Inc.'s CAGE code?

Pharmalucence, Inc.'s CAGE code is 0UB47.

What is Pharmalucence, Inc.'s primary NAICS code?

Pharmalucence, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Is Pharmalucence, Inc. registered in SAM.gov?

Pharmalucence, Inc.'s SAM.gov registration expired on November 4, 2022.

What is Pharmalucence, Inc.'s most recent federal award?

Pharmalucence, Inc.'s most recent federal contract award is Radiopharmaceticals and supples (W81K0024F0147), from Medical Command, on October 1, 2024.

On GovTribe

See Pharmalucence, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors